Genomic and non-genomic effects of dexamethasone on equine peripheral blood neutrophils

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 126-131

  Lecoq, L ^a   Vincent, P ^a   Lavoie Lamoureux, A ^a   Lavoie, J P ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Flow cytometry; Glucocorticoids; IL 8; RT PCR; RU486

Indexed keywords

DEXAMETHASONE; DICHLORODIHYDROFLUORESCEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE; PHORBOL 13 ACETATE 12 MYRISTATE; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HORSE; INCUBATION TIME; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; OXIDATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DACTINOMYCIN; DEXAMETHASONE; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HORSES; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; EQUIDAE;

EID: 60549110396     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.303     Document Type: Article

References (44)

1. al-Mokdad M., Shibata F., Takano K., and Nakagawa H. Differential production of chemokines by phagocytosing rat neutrophils and macrophages. Inflammation 22 (1998) 145-159
2. Bamberger C.M., Schulte H.M., and Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17 (1996) 245-261
3. Beato M., and Klug J. Steroid hormone receptors: an update. Hum. Reprod. Update 6 (2000) 225-236
4. Berndt A., Derksen F.J., Venta P.J., Ewart S., Yuzbasiyan-Gurkan V., and Robinson N.E. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L936-943
5. Cassatella M.A. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73 (1999) 369-509
6. Catley M. Dissociated steroids. Sci. World J. 7 (2007) 421-430
7. Cato A.C., Nestl A., and Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci. STKE 2002 (2002) RE9
8. Chang L.C., Madsen S.A., Toelboell T., Weber P.S., and Burton J.L. Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils. J. Endocrinol. 183 (2004) 569-583
9. Chen Y.Z., and Qiu J. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol. Cell. Biol. Res. Commun. 2 (1999) 145-149
10. Clark A.R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 275 (2007) 79-97
11. Cohen N.D., and Carter G.K. Steroid hepatopathy in a horse with glucocorticoid-induced hyperadrenocorticism. J. Am. Vet. Med. Assoc. 200 (1992) 1682-1684
12. Cornelisse C.J., Robinson N.E., Berney C.E., Kobe C.A., Boruta D.T., and Derksen F.J. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Equine Vet. J. 36 (2004) 426-430
13. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154 (1995) 4719-4725
14. Cox G., and Austin R.C. Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J. Leukoc. Biol. 61 (1997) 224-230
15. Eustace R.A., and Redden R.R. Iatrogenic laminitis. Vet. Rec. 126 (1990) 586
16. Fearon D.T., and Collins L.A. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J. Immunol. 130 (1983) 370-375
17. Franchini M., Gilli U., Akens M.K., Fellenberg R.V., and Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol. 66 (1998) 53-65
18. Garcia C., de Oliveira M.C., Verlengia R., Curi R., and Pithon-Curi T.C. Effect of dexamethasone on neutrophil metabolism. Cell Biochem. Funct. 21 (2003) 105-111
19. Giguere S., Viel L., Lee E., MacKay R.J., Hernandez J., and Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet. Immunol. Immunopathol. 85 (2002) 147-158
20. Goulding N.J., Euzger H.S., Butt S.K., and Perretti M. Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm. Res. 47 Suppl. 3 (1998) S158-165
21. Guelfi J.F., and Kraouchi D.E. The effect of a single dose of dexamethasone on the production of superoxide anion and on the chemotaxis of blood polynuclear neutrophils in the horse. Comp. Immunol. Microbiol. Infect. Dis. 12 (1989) 105-113
22. Honer C., Nam K., Fink C., Marshall P., Ksander G., Chatelain R.E., Cornell W., Steele R., Schweitzer R., and Schumacher C. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol. Pharmacol. 63 (2003) 1012-1020
23. Joubert P., Silversides D.W., and Lavoie J.P. Equine neutrophils express mRNA for tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-gamma. Equine Vet. J. 33 (2001) 730-733
24. Koukouritaki S.B., Theodoropoulos P.A., Margioris A.N., Gravanis A., and Stournaras C. Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover. J. Cell. Biochem. 62 (1996) 251-261
25. Lavoie J.P., Leguillette R., Pasloske K., Charette L., Sawyer N., Guay D., Murphy T., and Hickey G.J. Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction. Am. J. Vet. Res. 63 (2002) 579-585
26. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell. Biol. 4 (2003) 46-56
27. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., and Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83 (2003) 965-1016
28. Mahajan D.K., and London S.N. Mifepristone (RU486): a review. Fertil. Steril. 68 (1997) 967-976
29. Picandet V., Leguillette R., and Lavoie J.P. Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ('heaves'). Equine Vet. J. 35 (2003) 419-424
30. Raidal S.L., Bailey G.D., and Love D.N. Flow cytometric determination of oxidative burst activity of equine peripheral blood and bronchoalveolar lavage-derived leucocytes. Vet. J. 156 (1998) 117-126
31. Robinson N.E. International workshop on equine chronic airway disease. Michigan State University 16-18 June 2000. Equine Vet. J. 33 (2001) 5-19
32. Robinson N.E., Jackson C., Jefcoat A., Berney C., Peroni D., and Derksen F.J. Efficacy of three corticosteroids for the treatment of heaves. Equine Vet. J. 34 (2002) 17-22
33. Rush B.R., Flaminio M.J., Matson C.J., Hakala J.E., and Shuman W. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. Vet. Res. 59 (1998) 1033-1038
34. Rush B.R., Raub E.S., Rhoads W.S., Flaminio M.J., Matson C.J., Hakala J.E., and Gillespie J.R. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. Vet. Res. 59 (1998) 1039-1043
35. Rush B.R., Worster A.A., Flaminio M.J., Matson C.J., and Hakala J.E. Alteration in adrenocortical function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. Vet. Res. 59 (1998) 1044-1047
36. Schleimer R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc. Am. Thorac. Soc. 1 (2004) 222-230
37. Sibille Y., and Marchandise F.X. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur. Respir. J. 6 (1993) 1529-1543
38. Sibille Y., and Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141 (1990) 471-501
39. Stellato C. Post-transcriptional and nongenomic effects of glucocorticoids. Proc. Am. Thorac. Soc. 1 (2004) 255-263
40. Takahira R., Yonemura K., Fujise Y., and Hishida A. Dexamethasone attenuates neutrophil infiltration in the rat kidney in ischemia/reperfusion injury: the possible role of nitroxyl. Free Radic. Biol. Med. 31 (2001) 809-815
41. Vuorte J., Jansson S.E., and Repo H. Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay. Cytometry 43 (2001) 290-296
42. Wang D., Zhang H., Lang F., and Yun C.C. Acute activation of NHE3 by dexamethasone correlates with activation of SGK1 and requires a functional glucocorticoid receptor. Am. J. Physiol. Cell. Physiol. 292 (2007) C396-404
43. Weber P.S., Toelboell T., Chang L.C., Tirrell J.D., Saama P.M., Smith G.W., and Burton J.L. Mechanisms of glucocorticoid-induced down-regulation of neutrophil l-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils. J. Leukoc. Biol. 75 (2004) 815-827
44. Wertheim W.A., Kunkel S.L., Standiford T.J., Burdick M.D., Becker F.S., Wilke C.A., Gilbert A.R., and Strieter R.M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151 (1993) 2166-2175